Christopher W. Perrett
GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp.
Perrett, Christopher W.; Clayton, Richard N.; Pistorello, Matteo; Boscaro, Marco; Scanarini, Massimilio; Bates, Andrew S.; Buckley, Nicola; Jones, Peter; Fryer, Anthony A.; Gilford, Janice; Alldersea, Julie; Strange, Richard C.
Authors
Richard N. Clayton
Matteo Pistorello
Marco Boscaro
Massimilio Scanarini
Andrew S. Bates
Nicola Buckley
Peter Jones
Professor Anthony Fryer a.a.fryer@keele.ac.uk
Janice Gilford
Julie Alldersea
Richard C. Strange
Abstract
We describe studies to determine if susceptibility to pituitary tumours is associated with the putatively high risk GSTM1 null and CYP2D6 EM genotypes. Frequency distributions of these genotypes were similar in cases and controls though the frequency of CYP2D6 PM and GSTM1 B tended to be lower (P = 0.072 and P = 0.095 respectively) in the tumour group. Immunopositivity for p53 was found in 18/97 tumours. In these samples GSTM1 null (39%) and CYP2D6 EM (56%) frequencies were not different to those in controls. The frequencies of CYP2D6 PM and GSTM1 B in the p53 immunonegative tumours tended to be lower (P = 0.055 and P = 0.1185 respectively) than in controls. Mutations in gsp and ras were studied using the polymerase chain reaction and allele specific oligonucleotide analysis. Eight of 19 somatotrophinomas demonstrated mutations in gsp; frequencies of GSTM1 null and CYP2D6 EM were similar to controls. No ras mutations were identified in 55-tumour studies. The data indicate the GSTM1 null and CYP2D6 EM genotypes are not associated with altered expression of p53 or, mutation of gsp and ras in these adenomas and, suggest the CYP2D6 PM genotype is associated with a reduced risk of pituitary adenomas and, that GSTM1*B confers greater protection than GSTM1*A.
Citation
Perrett, C. W., Clayton, R. N., Pistorello, M., Boscaro, M., Scanarini, M., Bates, A. S., …Strange, R. C. (1995). GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp. Carcinogenesis, 16(7), 1643–1645. https://doi.org/10.1093/carcin/16.7.1643
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 10, 1995 |
Online Publication Date | Jul 1, 1995 |
Publication Date | 1995-07 |
Deposit Date | Feb 14, 2024 |
Journal | Carcinogenesis |
Print ISSN | 0143-3334 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 16 |
Issue | 7 |
Pages | 1643–1645 |
DOI | https://doi.org/10.1093/carcin/16.7.1643 |
Publisher URL | https://academic.oup.com/carcin/article/16/7/1643/268273 |
PMID | 7614700 |
You might also like
Monitoring drug interventions in people with bipolar disorder
(2023)
Journal Article
Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a 'Nearly Post COVID-19' World
(2022)
Presentation / Conference
Variability in test interval is linked to glycated haemoglobin (HbA1c) trajectory over time in people with diabetes
(2022)
Presentation / Conference
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search